Medtronic wants to prioritize restoring earnings power; Insulet has a Class I recall

Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, January 10, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Orthofix appointed a new CFO as Massimo Caliafiore took over as CEO. Fast Five hosts Danielle Kirsh and Sean Whooley discuss who takes on the financial leadership role and some of their career history.  Dexcom has submitted a new glucose sensor to the FDA and expects to launch it this summer. Whooley explains what the technology does and the launch plans Dexcom has. Megadyne Medical, part of J&J's Ethicon, has a new recall of patient return electrodes. The Fast Five hosts go over the reason behind the recall and what users of the device should do with the recalled technology. Insulet has a Class I recall for its Omnipod 5 Andrioid app. Hear the reason behind the recall and how it affects patients.  Medtronic's CEO Geoff Martha presented at the J.P. Morgan Conference this week and said the company is committed to prioritizing the restoration of its earnings power in the new year. Kirsh and Whooley some of Medtronic's target growth areas and how executives feel going into the new year.